The International Atomic Energy Agency published its final report following an 11-day mission to review Canada’s emergency preparedness and response framework for nuclear and radiological emergencies. The Emergency Preparedness Review (EPREV) was carried out at the request of the Canadian government, making Canada the first G7 country to request an EPREV mission and highlighting its commitment to … Read more
Health Canada released a statement: “During National Non-Smoking Week, the Council of Chief Medical Officers of Health (CCMOH) wants to highlight that smoking continues to pose a significant risk to the health of Canadians with over 45,000 people dying from smoking-related causes each year […] At this time, we also remain significantly concerned by the substantial … Read more
Health Minister Patty Hajdu (Thunder Bay-Superior North, Ont.) proposed new regulations to prohibit the promotion and advertising of vaping products anywhere they can be seen or heard by youth. Young Canadians will no longer see advertising for vaping products in public spaces, in convenience stores or online. Marketing of vaping products would be allowed only in specialty … Read more
Health Minister Patty Hajdu (Thunder Bay-Superior North, Ont.) issued the following statement on new cannabis products entering the legal and regulated market: “The Government of Canada legalized and regulated cannabis to keep it out of the hands of youth, and profits out of the pockets of criminals. To continue to achieve these objectives, edible cannabis, cannabis … Read more
Health Canada authorized a new treatment for women who have advanced endometrial cancer through the combined use of Lenvima (lenvatinib) and Keytruda (pembrolizumab). This was the first review conducted under Project Orbis, an initiative of the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence. Health Canada also authorized Calquence (acalabrutinib) for adults with chronic lymphocytic leukemia. This represents another treatment … Read more
Health Canada is providing Canadians with an update on the supply of tamoxifen, a breast cancer drug, and information on efforts to resolve the national shortage. Health Canada has worked collaboratively with companies, provinces and territories, and stakeholders, such as the Canadian Association of Provincial Cancer Agencies and health care professionals, to share information and identify mitigation … Read more
Health Canada is advising Canadians who use vaping products to monitor themselves for symptoms of pulmonary illness (e.g., cough, shortness of breath, chest pain) and to seek medical attention promptly if they have concerns about their health. Following the first confirmed case in Quebec in September, the Province of New Brunswick has now notified the Public Health Agency of Canada … Read more
In the wake of the recent cases of severe pulmonary illnesses and a number of deaths reportedly linked to the use of vaping products in the United States, Health Canada and the Public Health Agency of Canada provided national guidance to the provinces and territories on identifying cases of severe pulmonary illness related to vaping … Read more
Health Canada is advising Canadians that needle-free dermal filler devices that are promoted for cosmetic skin treatments—such as reducing wrinkles and increasing lip volume—may pose health risks. These small handheld medical devices used to deposit hyaluronic acid or other dermal fillers under the skin are also known as hyaluron pens, hyapens, fog injection devices, SERA … Read more
Health Canada is advising Canadians who use vaping products to monitor themselves for symptoms of pulmonary illness (e.g., cough, shortness of breath, chest pain) and to seek medical attention promptly if they have concerns about their health. This caution comes in the wake of the recent cases of acute pulmonary illnesses and one death reportedly linked … Read more
